Literature DB >> 10792423

Analysis of the phenotypic distribution of HLA class I and class II in atopic and non-atopic asthma patients.

A Torío1, I Sánchez-Guerrero, M Muro, N Herrero, J Pagán, A Minguela, L Marín, M R Moya-Quiles, M J Sanchís, M R Alvarez-López.   

Abstract

In several studies the HLA system has been implicated in the development of asthma, but the importance of the associations between HLA genes and asthma remains unclear. The aim of this study was to determine the HLA class I and II phenotypic frequencies in a population of asthmatics, and to analyse the relationship between these phenotypes and any type of asthma. We typed HLA class I and II antigens in a series of 189 asthmatic individuals (102 atopic and 87 non-atopic), and in a control population of 150 unrelated healthy Caucasoid donors. When the HLA phenotypic frequencies were compared, no statistical differences were found. Therefore, no definitive HLA association could be established with atopic or non-atopic asthma in the studied population. Abbreviations AA, atopic asthma; FEV1, forced expiratory volume in 1 s; NAA, non-atopic asthma; PCR, polymerase chain reaction; SSOP, sequence-specific oligonucleotide probes; SPT, skin prick test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792423     DOI: 10.1046/j.1365-2370.2000.00205.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  2 in total

1.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

2.  Influence of asthma epidemiology on the risk for other diseases.

Authors:  Young J Juhn
Journal:  Allergy Asthma Immunol Res       Date:  2012-01-27       Impact factor: 5.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.